ARGX · Argenx SE
$851.29
-5.65 (-0.66%)
At close · Aug 14
Market Cap
$52.69B
Shares
62.19M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ARGX
421 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| EUPAC Fund | — | 1,097,201 | $801,231,030 | 0.63% | Long | 2026-03-31 | |
| New Economy Fund | — | 713,694 | $596,641,047 | 1.16% | Long | 2026-05-31 | |
| Fidelity Growth Company Fund | — | 609,066 | $509,173,085 | 0.52% | Long | 2026-05-31 | |
| Fidelity OTC Portfolio | FREI | 532,626 | $447,672,153 | 1.23% | Long | 2026-01-31 | |
| Janus Henderson Forty Fund | — | 537,873 | $392,781,758 | 1.91% | Long | 2026-03-31 | |
| Fidelity OTC Portfolio | — | 480,126 | $375,324,097 | 0.93% | Long | 2026-04-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 435,310 | $317,885,128 | 2.92% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | AAXJ | 298,350 | $250,897,433 | 3.01% | Long | 2025-12-31 | |
| iShares Biotechnology ETF | — | 341,883 | $249,660,061 | 3.07% | Long | 2026-03-31 | |
| Janus Henderson Enterprise Fund | — | 309,064 | $225,693,986 | 1.10% | Long | 2026-03-31 | |
| Invesco American Franchise Fund | — | 245,620 | $205,335,864 | 1.12% | Long | 2026-05-31 | |
| T. Rowe Price Growth Stock Fund, Inc. | — | 271,558 | $198,305,230 | 0.45% | Long | 2026-03-31 | |
| T. Rowe Price Overseas Stock Fund | — | 234,879 | $183,609,612 | 0.72% | Long | 2026-04-30 | |
| Fidelity Puritan Fund | — | 209,689 | $175,297,907 | 0.52% | Long | 2026-05-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 216,283 | $157,940,661 | 1.24% | Long | 2026-03-31 | |
| T. Rowe Price Large-Cap Growth Fund | — | 212,294 | $155,027,694 | 0.83% | Long | 2026-03-31 | |
| Fidelity Advisor Growth Opportunities Fund | — | 181,699 | $151,898,547 | 0.43% | Long | 2026-05-31 | |
| Fidelity Contrafund | — | 196,730 | $143,662,083 | 0.09% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 171,204 | $143,124,832 | 0.52% | Long | 2026-05-31 | |
| Artisan Mid Cap Fund | — | 186,004 | $135,829,421 | 4.59% | Long | 2026-03-31 | |
| Janus Henderson Global Life Sciences Fund | — | 170,830 | $124,748,608 | 2.40% | Long | 2026-03-31 | |
| VIP Contrafund Portfolio | — | 165,180 | $120,622,695 | 0.45% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 141,444 | $118,245,770 | 2.25% | Long | 2026-05-31 | |
| Fidelity Series Growth Company Fund | — | 139,160 | $116,336,368 | 0.48% | Long | 2026-05-31 | |
| Janus Henderson Contrarian Fund | — | 144,283 | $105,362,661 | 2.46% | Long | 2026-03-31 | |
| Fidelity Advisor New Insights Fund | — | 134,732 | $98,388,043 | 0.42% | Long | 2026-03-31 | |
| T. Rowe Price International Stock Fund | — | 125,792 | $98,334,122 | 0.71% | Long | 2026-04-30 | |
| Lord Abbett Growth Leaders Fund | — | 122,831 | $96,019,449 | 1.27% | Long | 2026-04-30 | |
| Bridge Builder Small/Mid Cap Growth Fund | — | 126,617 | $92,462,064 | 1.00% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 108,000 | $90,286,920 | 1.56% | Long | 2026-05-31 | |
| Capital Group Global Growth Equity ETF | — | 98,382 | $82,246,368 | 0.73% | Long | 2026-05-31 | |
| Capital Group Global Growth Equity ETF | CGGO | 84,467 | $77,032,215 | 0.98% | Long | 2025-11-30 | |
| First Trust NYSE Arca Biotechnology Index Fund | — | 102,325 | $74,722,831 | 3.29% | Long | 2026-03-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 88,995 | $74,398,930 | 1.26% | Long | 2026-05-29 | |
| Fidelity Advisor Equity Growth Fund | — | 81,500 | $68,133,185 | 0.50% | Long | 2026-05-31 | |
| Janus Henderson Overseas Fund | — | 91,261 | $66,643,345 | 1.64% | Long | 2026-03-31 | |
| Fidelity Balanced Fund | — | 75,411 | $63,042,842 | 0.10% | Long | 2026-05-31 | |
| Janus Henderson Research Fund | — | 85,063 | $62,117,256 | 0.25% | Long | 2026-03-31 | |
| Artisan Global Opportunities Fund | — | 82,956 | $60,578,619 | 3.97% | Long | 2026-03-31 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 72,300 | $60,442,077 | 0.02% | Long | 2026-05-31 | |
| Fidelity Advisor Biotechnology Fund | — | 77,200 | $60,348,784 | 3.17% | Long | 2026-04-30 | |
| Invesco Main Street Fund | — | 75,211 | $58,793,943 | 0.52% | Long | 2026-04-30 | |
| ClearBridge Value Fund | — | 75,000 | $58,629,000 | 1.41% | Long | 2026-04-30 | |
| Fidelity Series Opportunistic Insights Fund | — | 77,400 | $56,521,350 | 0.42% | Long | 2026-03-31 | |
| Global Growth Fund | — | 76,588 | $55,928,387 | 0.65% | Long | 2026-03-31 | |
| Eventide Gilead Fund | — | 75,482 | $55,120,731 | 2.05% | Long | 2026-03-31 | |
| T. Rowe Price All-Cap Opportunities Fund | — | 75,069 | $54,819,137 | 0.38% | Long | 2026-03-31 | |
| VIP Growth Portfolio | — | 74,747 | $54,583,997 | 0.51% | Long | 2026-03-31 | |
| AB LARGE CAP GROWTH FUND INC | — | 67,260 | $52,578,487 | 0.22% | Long | 2026-04-30 | |
| Fidelity Advisor Health Care Fund | — | 65,000 | $50,811,800 | 1.76% | Long | 2026-04-30 |
Showing 1–50 of 421 positions